Quarterly report · Q1
4578.TEDINET S100QQZ3
Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥448.3bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥380.3bn | 2022-01-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥76.8bn | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥20.7bn | 2022-01-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥79.2bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥173.0bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥31.0bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥61.4bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥133.9bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥23.3bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥62.7bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥24.2bn | 2022-01-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥3.13T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥3.10T | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥2.89T | at 2022-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥811.5bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥840.3bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.32T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.26T | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.10T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.05T | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥2.28T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.23T | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥2.07T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥477.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥471.6bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥423.4bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥410.7bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥71.9bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥211.8bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥57.7bn | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥35.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥81.6bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥22.8bn | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥32.7bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥95.5bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥34.6bn | 2022-01-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥113.2 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥246.8 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥42.86 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥113.18 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥246.78 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥42.7 | 2022-01-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 72.8% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 71.7% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥42.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥33.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥9.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | ¥3.7bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥9.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥9.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥13.0bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥8.2bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥104.0bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥104.0bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥13m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥11.2bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥303.2bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥303.2bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥72.7bn |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥458.0bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥448.3bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥9.7bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥89.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-03-31 | ¥39.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-03-31 | ¥30.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥8.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-03-31 | ¥4.1bn |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-03-31 | −¥8.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-03-31 | −¥8.8bn |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-03-31 | −¥11.7bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥7.7bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥7.7bn |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥3m |
| jpcrp040300-q1r_E21183-000Consumer Productsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥235m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥90.3bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥90.3bn |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥3m |
| jpcrp040300-q1r_E21183-000Nutraceuticalsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥11.3bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥252.1bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥252.1bn |
| jpcrp040300-q1r_E21183-000Pharmaceuticalsreportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥17.3bn |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥389.1bn |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥380.3bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥8.8bn |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | ¥32.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 706
| Item | Context | Value | Unit |
|---|---|---|---|
| Other components of equity IFRS | CurrentQuarterInstant | 150484000000 | JPY |
| Equity attributable to owners of parent IFRS | Prior1YearInstant | 2225255000000 | JPY |
| Equity attributable to owners of parent IFRS | CurrentQuarterInstant | 2281415000000 | JPY |
| Non controlling interests IFRS | Prior1YearInstant | 37114000000 | JPY |
| Non controlling interests IFRS | CurrentQuarterInstant | 39174000000 | JPY |
| Equity IFRS | Prior1YearInstant | 2262369000000 | JPY |
| Equity IFRS | CurrentQuarterInstant | 2320590000000 | JPY |
| Liabilities and equity IFRS | Prior1YearInstant | 3102638000000 | JPY |
| Liabilities and equity IFRS | CurrentQuarterInstant | 3132041000000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 380308000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 448344000000 | JPY |
| Cost of sales IFRS | Prior1YTDDuration | 126340000000 | JPY |
| Cost of sales IFRS | CurrentYTDDuration | 136776000000 | JPY |
| Gross profit IFRS | Prior1YTDDuration | 253968000000 | JPY |
| Gross profit IFRS | CurrentYTDDuration | 311567000000 | JPY |
| Selling general and administrative expenses IFRS | Prior1YTDDuration | 154500000000 | JPY |
| Selling general and administrative expenses IFRS | CurrentYTDDuration | 175558000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | Prior1YTDDuration | 2346000000 | JPY |
| Share of profit loss of investments accounted for using equity method IFRS | CurrentYTDDuration | 5640000000 | JPY |
| Research and development expenditure recognized as expense during period IFRS | Prior1YTDDuration | 59347000000 | JPY |
| Research and development expenditure recognized as expense during period IFRS | CurrentYTDDuration | 67968000000 | JPY |
| Impairment losses pl IFRS | Prior1YTDDuration | 23831000000 | JPY |
| Impairment losses pl IFRS | CurrentYTDDuration | 211000000 | JPY |
| Other income IFRS | Prior1YTDDuration | 2358000000 | JPY |
| Other income IFRS | CurrentYTDDuration | 3848000000 | JPY |
| Other expenses IFRS | Prior1YTDDuration | 245000000 | JPY |
| Other expenses IFRS | CurrentYTDDuration | 538000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 20749000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 76779000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 11272000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 3884000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 1036000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 1421000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 30985000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 79242000000 | JPY |
| Income tax expense IFRS | Prior1YTDDuration | 6806000000 | JPY |
| Income tax expense IFRS | CurrentYTDDuration | 16579000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 24178000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 62663000000 | JPY |
| Profit loss attributable to owners of parent IFRS | Prior1YTDDuration | 23250000000 | JPY |
| Profit loss attributable to owners of parent IFRS | CurrentYTDDuration | 61430000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | Prior1YTDDuration | 928000000 | JPY |
| Profit loss attributable to non controlling interests IFRS | CurrentYTDDuration | 1232000000 | JPY |
| Profit loss IFRS | Prior1YTDDuration | 24178000000 | JPY |
| Profit loss IFRS | CurrentYTDDuration | 62663000000 | JPY |
| Basic earnings loss per share IFRS | Prior1YTDDuration | 42.86 | |
| Basic earnings loss per share IFRS | CurrentYTDDuration | 113.20 | |
| Diluted earnings loss per share IFRS | Prior1YTDDuration | 42.70 | |
| Diluted earnings loss per share IFRS | CurrentYTDDuration | 113.18 | |
| Profit loss IFRS | Prior1YTDDuration | 24178000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |